These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33325396)

  • 21. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
    Whitehair DC; Sherzai A; Emond J; Raman R; Aisen PS; Petersen RC; Fleisher AS;
    Alzheimers Dement; 2010 Sep; 6(5):412-9. PubMed ID: 20813342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation in Alzheimer's Disease: Do Sex and APOE Matter?
    Duarte-Guterman P; Albert AY; Inkster AM; Barha CK; Galea LAM;
    J Alzheimers Dis; 2020; 78(2):627-641. PubMed ID: 33016923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes Simplex Virus, APOEɛ4, and Cognitive Decline in Old Age: Results from the Betula Cohort Study.
    Lövheim H; Norman T; Weidung B; Olsson J; Josefsson M; Adolfsson R; Nyberg L; Elgh F
    J Alzheimers Dis; 2019; 67(1):211-220. PubMed ID: 30636735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    Cardoso R; Lemos C; Oliveiros B; Almeida MR; Baldeiras I; Pereira CF; Santos A; Duro D; Vieira D; Santana I; Oliveira CR
    J Alzheimers Dis; 2020; 78(2):587-601. PubMed ID: 33016906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status.
    Monsell SE; Besser LM; Heller KB; Checkoway H; Litvan I; Kukull WA
    Parkinsonism Relat Disord; 2014 May; 20(5):503-7. PubMed ID: 24582705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
    Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
    J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.
    Santiago JA; Potashkin JA
    PLoS One; 2015; 10(11):e0142582. PubMed ID: 26566043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Default Mode Network Connectivity Moderates the Relationship Between the APOE Genotype and Cognition and Individualizes Identification Across the Alzheimer's Disease Spectrum.
    Zhu Y; Gong L; He C; Wang Q; Ren Q; Xie C;
    J Alzheimers Dis; 2019; 70(3):843-860. PubMed ID: 31282419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein ɛ4 Affects Multiple Domains of Neuropsychological Functioning in a Sample of Elderly Hispanics.
    Oviedo DC; Perez-Lao AR; Flores-Cuadra JA; Villarreal AE; Carreira MB; Grajales SA; Britton GB
    J Alzheimers Dis; 2021; 82(s1):S313-S319. PubMed ID: 33074238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sex and APOE on Parkinson's Disease-related cognitive decline.
    Tipton PW; Bülbül N; Crook J; Quicksall Z; Ross OA; Uitti RJ; Wszolek ZK; Ertekin-Taner N
    Neurol Neurochir Pol; 2021; 55(6):559-566. PubMed ID: 34642926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
    Mengel D; Dams J; Ziemek J; Becker J; Balzer-Geldsetzer M; Hilker R; Baudrexel S; Kalbe E; Schmidt N; Witt K; Liepelt-Scarfone I; Gräber S; Petrelli A; Neuser P; Schulte C; Linse K; Storch A; Wittchen HU; Riedel O; Mollenhauer B; Ebentheuer J; Trenkwalder C; Klockgether T; Spottke A; Wüllner U; Schulz JB; Reetz K; Heber IA; Ramirez A; Dodel R
    Parkinsonism Relat Disord; 2016 Aug; 29():112-6. PubMed ID: 27321987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease.
    Williams-Gray CH; Goris A; Saiki M; Foltynie T; Compston DA; Sawcer SJ; Barker RA
    J Neurol; 2009 Mar; 256(3):493-8. PubMed ID: 19308307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease.
    Karcher H; Savelieva M; Qi L; Hummel N; Caputo A; Risson V; Capkun G; Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2020; 17(7):635-657. PubMed ID: 33032508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual Memory Deficits in Middle-Aged APOEɛ4 Homozygotes Detected Using Unsupervised Cognitive Assessments.
    Lim YY; Pase MP; Buckley RF; Yassi N; Bransby L; Fowler C; Laws SM; Masters CL; Maruff P
    J Alzheimers Dis; 2021; 79(4):1563-1573. PubMed ID: 33492293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing the Effects of Sex, APOE ɛ4, and Literacy on Mid-life Cognitive Trajectories: Application of Information-Theoretic Model Averaging and Multi-model Inference Techniques to the Wisconsin Registry for Alzheimer's Prevention Study.
    Koscik RL; Norton DL; Allison SL; Jonaitis EM; Clark LR; Mueller KD; Hermann BP; Engelman CD; Gleason CE; Sager MA; Chappell RJ; Johnson SC
    J Int Neuropsychol Soc; 2019 Feb; 25(2):119-133. PubMed ID: 30522545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment.
    Samat NA; Abdul Murad NA; Mohamad K; Abdul Razak MR; Mohamed Ibrahim N
    Front Neurosci; 2017; 11():712. PubMed ID: 29326545
    [No Abstract]   [Full Text] [Related]  

  • 39. Association Between APOE Alleles and Change of Neuropsychological Tests in the Long Life Family Study.
    Du M; Andersen SL; Schupf N; Feitosa MF; Barker MS; Perls TT; Sebastiani P
    J Alzheimers Dis; 2021; 79(1):117-125. PubMed ID: 33216038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting At-Risk Alzheimer's Disease Cases.
    Fladby T; Pålhaugen L; Selnes P; Waterloo K; Bråthen G; Hessen E; Almdahl IS; Arntzen KA; Auning E; Eliassen CF; Espenes R; Grambaite R; Grøntvedt GR; Johansen KK; Johnsen SH; Kalheim LF; Kirsebom BE; Müller KI; Nakling AE; Rongve A; Sando SB; Siafarikas N; Stav AL; Tecelao S; Timon S; Bekkelund SI; Aarsland D
    J Alzheimers Dis; 2017; 60(1):97-105. PubMed ID: 28826181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.